Chemokine Therapeutics
Chemokine Therapeutics incurs net loss of $6 million for 2005
Published in Cardiovascular Business Week, May 2nd, 2006
Chemokine Therapeutics achieved a number of important milestones in its first year operating as a public company including:
Release of results of phase I clinical trials for the company's immune booster drug CTCE-0214 in healthy volunteers: the company confirmed that the safety profile and efficacy results from the phase I trial of CTCE-0214 warrant continued development;
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Arrow International
Arrow International reports earnings of $0.28 per share - Finance
Anthem Blue Cross and Blue Shield in Virginia awards $12M to 41 hospitals - PharmaFrontiers Corp.
PharmaFrontiers reports net loss for the full year 2005 was $19.4 million - RegeneRx Biopharmaceuticals, Inc.
RegeneRx reports net loss of $5.5 million - Roche
Roche Foundation for Anaemia Research to award new grant worth over US$1.8 million - Sorin Group
Sorin Group's 2005 results show profitability up sharply, restructuring bringing benefits - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
